Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient-centered, Optimal Integration of Survivorship and Palliative Care

NCT04900935 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04900935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04900935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient-centered, Optimal Integration of Survivorship and Palliative Care
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 29, 2023
Completion date
September 1, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alk-positive non-small cell lung cancer, carcinoma, non-small-cell lung, egfr positive non-small cell lung cancer, nonsmall cell lung cancer, palliative care, stage iv non-small cell lung cancer, survivorship, targeted therapy